Clinical Research Management Briefing – February 26, 2018

Top Stories

CRISPR Could End Sickle Cell Disease, But Signing Up Black Patients for Clinical Trials Will Be a Hard Sell

A history of unethical biomedical treatment in African-American communities could make recruiting patients difficult for researchers.

STAT, February 21

Trump Pushing Ahead on Koch-Backed Experimental Drugs 'Right to Try' Agenda

Bypassing the Food and Drug Administration's clinical-trial process is raising safety and ethical concerns among patient-advocacy organizations.

CNBC, February 21

Huron Spotlight

Emory University Goes Live on Huron IACUC 8.1

In just five months, Emory University deployed Huron IACUC to streamline operations and better manage its protocols.

Huron

Financial and Operations

Distributed Ledgers Can Streamline Clinical Trials

New technology has the potential to streamline healthcare processes – bringing new drugs to the market faster and at a lower price.

Nasdaq, February 15

Technology

Sensors and Wearables Transform Clinical Trials but Challenges Remain, Experts Say

Inconsistencies in the way devices measure, report and collect data make selecting the right device even more important.

CenterWatch, February 19

Pharma/Bio-Tech

What Pharma Companies Need to Know about FDA's New Draft IVD Guidance

With the increased use of in vitro diagnostics (IVDs), pharmaceutical and biotech companies need to develop guidelines for risk evaluation and consideration.

Applied Clinical Trials, February 12